Advertisement

Effects of HIV on Liver Cell Populations

  • Meena B. Bansal
  • Jason T. Blackard
Chapter

Abstract

Approximately one third of the body’s blood supply passes through the liver each minute [1], and the majority of the blood flow is derived from the portal circulation. As blood enters the liver, it is distributed through the hepatic sinusoids, which are lined by a uniquely fenestrated endothelium interspersed with resident hepatic macrophages, also known as Kupffer cells.

Keywords

Kupffer Cell Long Terminal Repeat Microbial Translocation Liver Sinusoidal Endothelial Cell Liver Cell Population 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Sheth K, Bankey P. The liver as an immune organ. Curr Opin Crit Care. 2001;7:99–104.PubMedCrossRefGoogle Scholar
  2. 2.
    Kahn J, Walker B. Acute human immunodeficiency virus type 1 infection. N Engl J Med. 1998;339(1):33–9.PubMedCrossRefGoogle Scholar
  3. 3.
    Keaveny AP, Karasik M. Hepatobiliary and pancreatic infections in AIDS: Part one. AIDS Patient Care STDS. 1998;12(5):347–57.PubMedCrossRefGoogle Scholar
  4. 4.
    Bonacini M. Hepatobiliary complications in patients with human immunodeficiency virus infection. Am J Med. 1992;92:404–11.PubMedCrossRefGoogle Scholar
  5. 5.
    Lefkowitch J. Pathology of AIDS-related liver disease. Dig Dis. 1994;12:321–30.PubMedCrossRefGoogle Scholar
  6. 6.
    Cao Y et al. CD4-independent, productive human immunodeficiency virus type 1 infection of hepatoma cell lines in vitro. J Virol. 1990;64(6):2553–9.PubMedGoogle Scholar
  7. 7.
    Vlahakis S et al. Human immunodeficiency virus-induced apoptosis of human hepatocytes via CXCR4. J Infect Dis. 2003;188: 1455–60.PubMedCrossRefGoogle Scholar
  8. 8.
    Littman D. Chemokine receptors: keys to AIDS pathogenesis? Cell Death Differ. 1998;93(5):677–80.Google Scholar
  9. 9.
    Popik W, Pitha P. Exploitation of cellular signaling by HIV-1: unwelcome guests with master keys that signal their entry. Virology. 2000;276(1):1–6.PubMedCrossRefGoogle Scholar
  10. 10.
    Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity. 2000;12:121–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Mellado M et al. Chemokine signaling and functional responses: the role of receptor dimerization and TK pathway activation. Annu Rev Immunol. 2001;19:397–421.PubMedCrossRefGoogle Scholar
  12. 12.
    Pearce-Pratt R, Malamud D, Phillips D. Role of the cytoskeleton in cell-to-cell transmission of human immunodeficiency virus. J Virol. 1994;68(5):2898–905.PubMedGoogle Scholar
  13. 13.
    Douglas GC et al. Cell-mediated infection of human placental trophoblast with HIV in vitro. AIDS Res Hum Retroviruses. 1991;7(9): 735–40.PubMedCrossRefGoogle Scholar
  14. 14.
    Hatsukari I et al. DEC-205-mediated internalization of HIV-1 results in the establishment of silent infection in renal tubular cells. J Am Soc Nephrol. 2007;18(3):780–7.PubMedCrossRefGoogle Scholar
  15. 15.
    Lusso P, Lori F, Gallo R. CD4-independent infection by human immunodeficiency virus type 1 after phenotypic mixing with human T-cell leukemia viruses. J Virol. 1990;64(12):6341–4.PubMedGoogle Scholar
  16. 16.
    Harouse JM et al. CD4-independent infection of human neural cells by human immunodeficiency virus type 1. J Virol. 1989;63(6): 2527–33.PubMedGoogle Scholar
  17. 17.
    Liu Y et al. CD4-independent infection of astrocytes by human immunodeficiency virus type 1: requirement for the human mannose receptor. J Virol. 2004;78(8):4120–33.PubMedCrossRefGoogle Scholar
  18. 18.
    Bhattacharya J, Peters PJ, Clapham P. CD4-independent infection of HIV and SIV: implications for envelope conformation and cell tropism in vivo. AIDS. 2003;17 Suppl 4:S3–43.Google Scholar
  19. 19.
    Cameron P et al. Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells. Science. 1992;257:383–7.PubMedCrossRefGoogle Scholar
  20. 20.
    Geijtenbeek T et al. DC-SIGN, a dendritic cell-specific HIV-1 binding protein that enhances trans-infection of T cells. Cell. 2000;100: 587–97.PubMedCrossRefGoogle Scholar
  21. 21.
    Nguyen DG, Hildreth J. Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophages. Eur J Immunol. 2003;33(2):483–93.PubMedCrossRefGoogle Scholar
  22. 22.
    Chen P et al. Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses. J Virol. 2007;81: 12582–95.PubMedCrossRefGoogle Scholar
  23. 23.
    Popik W, Pitha P. Exploitation of cellular signaling by HIV-1: unwelcome guests with master keys that signal their entry. Virology. 2000;2000:1–6.CrossRefGoogle Scholar
  24. 24.
    Zheng J et al. gp120-independent HIV infection of cells derived from the female reproductive tract, brain, and colon. J Acquir Immune Defic Syndr. 2006;43(2):137–6.CrossRefGoogle Scholar
  25. 25.
    Vidricaire G, Gauthier S, Tremblay M. HIV-1 infection of ­trophoblasts is independent of gp120/CD4 interactions but relies on heparan sulfate proteoglycans. J Infect Dis. 2007;195(10): 1461–71.PubMedCrossRefGoogle Scholar
  26. 26.
    Chow YH et al. gp120-Independent infection of CD4(−) epithelial cells and CD4(+) T-cells by HIV-1. J Acquir Immune Defic Syndr. 2002;30(1):1–8.PubMedGoogle Scholar
  27. 27.
    Klasse P, Moore J. Is there enough gp120 in the body fluids of HIV-1 infected individuals to have biologically significant effects. Virology. 2004;323:1–8.PubMedCrossRefGoogle Scholar
  28. 28.
    Popovic M et al. Perisistence of HIV-1 structural proteins and ­glycoproteins in lymph nodes of patients under highly active ­antiretroviral therapy. Proc Natl Acad Sci U S A. 2005;102: 14807–12.PubMedCrossRefGoogle Scholar
  29. 29.
    Santosuosso M et al. HIV-1 envelope protein gp120 is present at high concentrations in secondary lymphoid organs of individuals with chronic HIV-1 infection. J Infect Dis. 2009;200(7):1050–3.PubMedCrossRefGoogle Scholar
  30. 30.
    Cummins NW, Rizza SA, Badley AD. How much gp120 is there? J Infect Dis. 2010;201(8):1273–4. author reply 1274–5.PubMedCrossRefGoogle Scholar
  31. 31.
    Blackard JT, Sherman K. HCV/HIV co-infection: time to re-evaluate the role of HIV in the liver? J Viral Hepat. 2008;15(5):323–30.PubMedCrossRefGoogle Scholar
  32. 32.
    Cao Y et al. Identification and quantitation of HIV-1 in the liver of patients with AIDS. AIDS. 1992;6(1):65–70.PubMedCrossRefGoogle Scholar
  33. 33.
    Housset C, Lamas E, Brechot C. Detection of HIV1 RNA and p24 antigen in HIV-1-infected human liver. Res Virol. 1990;141:153–9.PubMedCrossRefGoogle Scholar
  34. 34.
    Jiang TJ et al. Immunohistochemical evidence for HIV-1 infection in the liver of HIV-infected patients. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2005;19(2):152–4.PubMedGoogle Scholar
  35. 35.
    Hoda SA, White JE, Gerber M. Immunohistochemical studies of human immunodeficiency virus-1 in liver tissues of patients with AIDS. Mod Pathol. 1991;4(5):578–81.PubMedGoogle Scholar
  36. 36.
    Lang ZW et al. A pathological study on liver tissues of patients with HIV infection. Zhonghua Gan Zang Bing Za Zhi. 2005;13(12): 930–2.PubMedGoogle Scholar
  37. 37.
    Banerjee R et al. Inhibition of HIV-1 productive infection in hepatoblastoma HepG2 cells by recombinant tumor necrosis factor-a. AIDS. 1992;6(10):1127–31.PubMedCrossRefGoogle Scholar
  38. 38.
    Munshi N et al. Hepatitis C and human immunodeficiency virus envelope proteins cooperatively induce hepatocytic apoptosis via an innocent bystander mechanism. J Infect Dis. 2003;188:1192–204.PubMedCrossRefGoogle Scholar
  39. 39.
    Balasubramanian A, Ganju R, Groopman J. HCV and HIV envelope proteins collaboratively mediate IL-8 secretion through activation of p38 MAP kinase and SHP2 in hepatocytes. J Biol Chem. 2003;278(37):35755–66.PubMedCrossRefGoogle Scholar
  40. 40.
    Iser DM et al. Coinfection of hepatic cell lines with human immunodeficiency virus and hepatitis B virus leads to an increase in intracellular hepatitis B surface antigen. J Virol. 2010;84(12): 5860–7.PubMedCrossRefGoogle Scholar
  41. 41.
    Balasubramanian A et al. Molecular mechanism of hepatic injury in coinfection with hepatitis C virus and HIV. Clin Infect Dis. 2005;41 Suppl 1:S32–7.PubMedCrossRefGoogle Scholar
  42. 42.
    Babu CK et al. HIV induces TRAIL sensitivity in hepatocytes. PLoS One. 2009;4(2):e4623.PubMedCrossRefGoogle Scholar
  43. 43.
    Balasubramanian A, Ganju RK, Groopman JE. Signal transducer and activator of transcription factor 1 mediates apoptosis induced by hepatitis C virus and HIV envelope proteins in hepatocytes. J Infect Dis. 2006;194(5):670–81.PubMedCrossRefGoogle Scholar
  44. 44.
    Gao B. Cytokines, STATs and liver disease. Cell Mol Immunol. 2005;2(2):92–100.PubMedGoogle Scholar
  45. 45.
    Polyak S et al. Elevated levels of interleukin-8 in serum are associated with hepatitis C infection and resistance to interferon therapy. J Virol. 2001;75(13):6209–11.PubMedCrossRefGoogle Scholar
  46. 46.
    Polyak S et al. Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response. J Virol. 2001;75(13):6095–106.PubMedCrossRefGoogle Scholar
  47. 47.
    Khabar K et al. The alpha chemokine, interleukin 8, inhibits the antiviral action of interferon a. J Exp Med. 1997;186(7):1077–85.PubMedCrossRefGoogle Scholar
  48. 48.
    Canbay A, Friedman S, Gores G. Apoptosis: the nexus of liver injury and fibrosis. Hepatology. 2004;39:273–8.PubMedCrossRefGoogle Scholar
  49. 49.
    Altavilla G et al. Enhancement of chemical carcinogenesis by the HIV-1 tat gene. Am J Pathol. 2000;157(4):1081–9.PubMedCrossRefGoogle Scholar
  50. 50.
    Xiao P et al. Characterization of a CD4-independent clinical HIV-1 that can efficiently infect human hepatocytes through chemokine (C-X-C motif) receptor 4. AIDS. 2008;22(14):1749–57.PubMedCrossRefGoogle Scholar
  51. 51.
    Fromentin R, MR T, Tremblay M. Human hepatoma cells transmit surface bound HIV-1 to CD4+ T cells through an ICAM-1/LFA-1-dependent mechanism. Virology. 2010;398:168–75.PubMedCrossRefGoogle Scholar
  52. 52.
    Zhu M, Duan L, Pomerantz R. TAR- and Tat-independent replication of human immunodeficiency virus type 1 in human hepatoma cells. AIDS Res Hum Retroviruses. 1996;12(12):1093–101.PubMedCrossRefGoogle Scholar
  53. 53.
    Pizzella T, Banerjee R. Identification of a human immunodeficiency virus type 1 TAR binding protein in human hepatoblastoma HepG2 cells that trans-activates HIV-1 LTR-directed gene expression. DNA Cell Biol. 1994;13(1):67–74.PubMedCrossRefGoogle Scholar
  54. 54.
    Hsu ML et al. Cytokine regulation of HIV-1 LTR transactivation in human hepatocellular carcinoma cell lines. Cancer Lett. 1995;94(1): 41–8.PubMedCrossRefGoogle Scholar
  55. 55.
    Schmitt MP et al. Multiplication of human immunodeficiency virus in primary cultures of human kupffer cells – possible role of liver macrophage infection in the physiopathology of AIDS. Res Virol. 1990;141:143–52.PubMedCrossRefGoogle Scholar
  56. 56.
    Steffan A et al. Primary cultures of endothelial cells from the human liver sinusoid are permissive for human immunodeficiency virus type 1. Proc Natl Acad Sci U S A. 1992;89:1582–6.PubMedCrossRefGoogle Scholar
  57. 57.
    Ana C, Tuyama A, Hong F, Saiman Y, Wang C, Mosoian A, et al. HIV infects human hepatic stellate cells and promotes collagen I and MCP-1 expression: implications for hepatic fibrosis in HIV/HCV coinfection. Hepatology. 2010;52:612–21.CrossRefGoogle Scholar
  58. 58.
    Hong F et al. Hepatic stellate cells express functional CXCR4: role in stromal cell-derived factor-1alpha-mediated stellate cell activation. Hepatology. 2009;49(6):2055–67.PubMedCrossRefGoogle Scholar
  59. 59.
    Schwabe R, Bataller R, Brenner D. Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration. Am J Physiol Gastrointest Liver Physiol. 2003;285:G949–58.PubMedGoogle Scholar
  60. 60.
    Bruno R et al. gp120 modulates the biology of human hepatic stellate cells: a link between HIV infection and liver fibrogenesis. Gut. 2010;59(4):513–20.PubMedCrossRefGoogle Scholar
  61. 61.
    Hong F, Bansal M. HIV gp120(X4) promotes hepatic stellate cell activation, fibrogenesis, and proliferation: a potential mechanism for rapid fibrosis progression in HIV/HCV coinfected patients. Hepatology. 2009;50(4) Suppl:128A.Google Scholar
  62. 62.
    Scoazec JY et al. Peliosis hepatis and sinusoidal dilation during infection by the human immunodeficiency virus (HIV): an ultrastructural study. Am J Pathol. 1988;131(1):38–47.PubMedGoogle Scholar
  63. 63.
    Scoazec JY, Feldmann G. Both macrophages and endothelial cells of the human hepatic sinusoid express the CD4 molecule, a receptor for the human immunodeficiency virus. Hepatology. 1990;12(1):505–10.PubMedCrossRefGoogle Scholar
  64. 64.
    Lafon ME et al. HIV-1 infection induces functional alterations in human liver endothelial cells in primary culture. AIDS. 1994;8(6):747–52.PubMedCrossRefGoogle Scholar
  65. 65.
    Lafon ME et al. Interaction of human immunodeficiency virus with human macrovascular endothelial cells in vitro. AIDS Res Hum Retroviruses. 1992;8(9):1567–70.PubMedCrossRefGoogle Scholar
  66. 66.
    Bashirova AA et al. A dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection. J Exp Med. 2001;193(6):671–8.PubMedCrossRefGoogle Scholar
  67. 67.
    Hufert FT et al. Human Kupffer cels infected with HIV-1 in vivo. J Acquir Immune Defic Syndr. 1993;6(7):772–7.PubMedGoogle Scholar
  68. 68.
    Schweitzer C et al. Morphine stimulates HIV replication in primary cultures of human Kupffer cells. Res Virol. 1991;142(2–3):189–95.PubMedCrossRefGoogle Scholar
  69. 69.
    Balagopal A et al. Kupffer cells are depleted with HIV immunodeficiency and partially recovered with antiretroviral immune reconstitution. AIDS. 2009;23(18):2397–404.PubMedCrossRefGoogle Scholar
  70. 70.
    Gendrault JL et al. Interaction of cultured human Kupffer cells with HIV-infected CEM cells: an electron microscopic study. Pathobiology. 1991;59(4):223–6.PubMedCrossRefGoogle Scholar
  71. 71.
    Bautista AP. Impact of alcohol on the ability of Kupffer cells to produce chemokines and its role in alcoholic liver disease. J Gastroenterol Hepatol. 2000;15(4):349–56.PubMedCrossRefGoogle Scholar
  72. 72.
    Bautista AP. Chronic alcohol intoxication induces hepatic injury through enhanced macrophage inflammatory protein-2 production and intercellular adhesion molecule-1 expression in the liver. Hepatology. 1997;25(2):335–42.PubMedCrossRefGoogle Scholar
  73. 73.
    Jacobson-Brown P, Neuman M. Immunopathogenesis of hepatitis C viral infection: Th1/Th2 responses and the role of cytokines. Clin Biochem. 2001;34:167–71.PubMedCrossRefGoogle Scholar
  74. 74.
    Spanakis N et al. Cytokine serum levels in patients with chronic HCV infection. J Clin Lab Anal. 2002;16:40–6.PubMedCrossRefGoogle Scholar
  75. 75.
    Fukuda R et al. Intrahepatic expression of pro-inflammatory cytokine mRNAs and interferon efficacy in chronic hepatitis C. Liver. 1996;16:390–9.PubMedGoogle Scholar
  76. 76.
    Shimoda K et al. Interleukin-8 and hIRH (SDF1-a/PBSF) mRNA expression and histological activity index in patients with chronic hepatitis C. Hepatology. 1998;28(1):108–15.PubMedCrossRefGoogle Scholar
  77. 77.
    Neuman M et al. Serum tumour necrosis factor-a and transforming growth factor-b levels in chronic hepatitis C patients are immunomodulated by therapy. Cytokine. 2002;17(2):108–17.PubMedCrossRefGoogle Scholar
  78. 78.
    Gochee P et al. Steatosis in chronic hepatitis C: association with increased messenger RNA expression of collagen I, tumor necrosis factor-a and cytochrome P4502E1. J Gastroenterol Hepatol. 2003;18:386–92.PubMedCrossRefGoogle Scholar
  79. 79.
    Schuppan D et al. Hepatitis C and liver fibrosis. Cell Death Differ. 2002;10 Suppl 1:S59–67.Google Scholar
  80. 80.
    Pal S, Schnapp L. HIV-infected lymphocytes regulate fibronectin synthesis by TGFb1 secretion. J Immunol. 2004;172:3189–95.PubMedGoogle Scholar
  81. 81.
    Navikas V et al. Increased levels of interferon-gamma(IFN-gamma), IL-4 and tranforming growth factor-beta (TGF-beta) mRNA expressing blood mononuclear cells in human HIV infection. Clin Exp Immunol. 1994;96:59–63.PubMedCrossRefGoogle Scholar
  82. 82.
    Blackard J et al. Intrahepatic cytokine expression is downregulated during HCV/HIV co-infection. J Med Virol. 2006;78:202–7.PubMedCrossRefGoogle Scholar
  83. 83.
    Lin W et al. HIV increases HCV replication in a TGF-beta1-dependent manner. Gastroenterology. 2008;164(3):803–11.CrossRefGoogle Scholar
  84. 84.
    Friedman S. Cytokines and fibrogenesis. Semin Liver Dis. 1999;19(2):129–40.PubMedCrossRefGoogle Scholar
  85. 85.
    Masaki N, Fukushima S, Hayashi S. Lower Th-1/Th-2 ratio before interferon therapy may favor long-term virological responses in patients with chronic hepatitis C. Dig Dis Sci. 2002;47(10):2163–9.PubMedCrossRefGoogle Scholar
  86. 86.
    Breen E. Pro- and anti-inflammatory cytokines in human immunodeficiency virus infection and acquired immunodeficiency syndrome. Pharmacol Ther. 2002;95(3):295–304.PubMedCrossRefGoogle Scholar
  87. 87.
    Mehta S et al. The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection. Hepatology. 2005;41(1):123–31.PubMedCrossRefGoogle Scholar
  88. 88.
    Qurishi N et al. Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection. Lancet. 2003;362:1708–13.PubMedCrossRefGoogle Scholar
  89. 89.
    Kuntzen T et al. Intrahepatic mRNA expression in hepatitis C virus and HIV/hepatitis C virus co-infection: infiltrating cells, cytokines, and influence of HAART. AIDS. 2008;22(2):203–10.PubMedCrossRefGoogle Scholar
  90. 90.
    Mehandru S et al. Mechanisms of gastrointestinal CD4+ T-cell depletion during acute and early human immunodeficiency virus type 1 infection. J Virol. 2007;81(2):599–612.PubMedCrossRefGoogle Scholar
  91. 91.
    Brenchley J et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12:1365–71.PubMedCrossRefGoogle Scholar
  92. 92.
    Balagopal A et al. Human immunodeficiency virus-related microbial translocation and progression of hepatitis C. Gastroenterology. 2008;135(1):226–33.PubMedCrossRefGoogle Scholar
  93. 93.
    Seki E et al. TLR4 enhances TGF-beta signaling and hepatic ­fibrosis. Nat Med. 2007;13(11):1324–32.PubMedCrossRefGoogle Scholar
  94. 94.
    Paik YH et al. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology. 2003;37(5):1043–55.PubMedCrossRefGoogle Scholar
  95. 95.
    Moriuchi M et al. Exposure to bacterial products renders macrophages highly susceptible to T-tropic HIV-1. J Clin Invest. 1998;102(8):1540–50.PubMedCrossRefGoogle Scholar
  96. 96.
    Tedaldi E et al. Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy. Clin Infect Dis. 2003;36:363–7.PubMedCrossRefGoogle Scholar
  97. 97.
    Bica I et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis. 2001;32:492–7.PubMedCrossRefGoogle Scholar
  98. 98.
    Salmon-Ceron D et al. Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol. J Hepatol. 2005;42(6):799–805.PubMedCrossRefGoogle Scholar
  99. 99.
    Shi J et al. A meta-analysis of case-control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China. Br J Cancer. 2005;92(3): 607–12.PubMedGoogle Scholar
  100. 100.
    World Health Organization. Fact Sheet, Hepatitis B. 2000. 10 Apr 2003. Available from: http://www.who.int/inf-fs/en/fact204.html.
  101. 101.
    Colin JF et al. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology. 1999;29(4):1306–10.PubMedCrossRefGoogle Scholar
  102. 102.
    Gilson RJ et al. Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection. AIDS. 1997;11(5):597–606.PubMedCrossRefGoogle Scholar
  103. 103.
    Yokozaki S et al. Immunological dynamics in hemophiliac patients infected with hepatitis C and human immunodeficiency virus: influence of antiretroviral therapy. Blood. 2000;96(13):4293–9.PubMedGoogle Scholar
  104. 104.
    Thomas D et al. Multicenter evaluation of hepatitis C RNA levels among female injection drug users. J Infect Dis. 2001;183:973–6.PubMedCrossRefGoogle Scholar
  105. 105.
    Daar E et al. Hepatitis C viral load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs. J Infect Dis. 2001;193:589–95.CrossRefGoogle Scholar
  106. 106.
    Greub G et al. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet. 2000;356:1800–5.PubMedCrossRefGoogle Scholar
  107. 107.
    Braitstein P et al. Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort. AIDS. 2006;20(3):323–31.PubMedCrossRefGoogle Scholar
  108. 108.
    Piroth L et al. Hepatitis C virus co-infection is a negative prognostic factor for clinical evolution in human immunodeficiency virus-positive patients. J Viral Hepat. 2000;7(4):302–8.PubMedCrossRefGoogle Scholar
  109. 109.
    Piroth L et al. Does hepatitis C virus co-infection accelerate ­clinical and immunological evolution of HIV-infected patients? AIDS. 1998;12(4):381–8.PubMedCrossRefGoogle Scholar
  110. 110.
    Macias J et al. Impaired recovery of CD4+ cell counts following highly active antiretroviral therapy in drug-naive patients coinfected with human immunodeficiency virus and hepatitis C virus. Eur J Clin Microbiol Infect Dis. 2003;22:675–80.PubMedCrossRefGoogle Scholar
  111. 111.
    Ruys T, et al. Impaired recovery of CD4 cells in HIV-1 HCV co-infected patients using highly active antiretroviral therapy. In XV International AIDS Conference. Bangkok, Thailand. 2004.Google Scholar
  112. 112.
    Anderson K, Guest J, Rimland D. Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: data from the HIV Atlanta Cohort Study. Clin Infect Dis. 2004;39:1507–13.PubMedCrossRefGoogle Scholar
  113. 113.
    Wu X et al. HCV NS3/4A protein activates HIV-1 transcription from its long terminal repeat. Virus Res. 2008;135(1):155–60.PubMedCrossRefGoogle Scholar
  114. 114.
    Srinivas R et al. Hepatitis C virus core protein inhibits human immunodeficiency virus type 1 replication. Virus Res. 1996;45(2):87–92.PubMedCrossRefGoogle Scholar
  115. 115.
    Ray RB et al. Transcriptional regulation of cellular and viral ­promoters by the hepatitis C virus core protein. Virus Res. 1995;37(3):209–20.PubMedCrossRefGoogle Scholar
  116. 116.
    Balsano C et al. The hepatitis B virus X gene product transactivates the HIV-LTR in vivo. Arch Virol. 1993;8:63–71.Google Scholar
  117. 117.
    Gomez-Gonzalo M et al. The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter. J Biol Chem. 2001;276(38):35435–43.PubMedCrossRefGoogle Scholar
  118. 118.
    Ma G, et al. HIV infection of an HCV-producing hepatocyte cell line – a model system for exploring HIV-HCV co-infection in vitro. In 13th International Symposium on Viral Hepatitis and Liver Disease. Washington, DC. 2009.Google Scholar
  119. 119.
    Tardif MR, Tremblay M. Tetraspanin CD81 provides a costimulatory signal resulting in increased human immunodeficiency virus type 1 gene expression in primary CD4+ T lymphocytes through NF-kappaB, NFAT, and AP-1 transduction pathways. J Virol. 2005;79(7):4316–28.PubMedCrossRefGoogle Scholar
  120. 120.
    Gordón-Alonso M et al. Tetraspanins CD9 and CD81 modulate HIV-1-induced membrane fusion. J Immunol. 2006;177(8):5129–37.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Department of MedicineMount Sinai School of MedicineNew YorkUSA
  2. 2.Division of Digestive DiseasesUniversity of Cincinnati College of MedicineCincinnatiUSA

Personalised recommendations